VivaQuant, LLC
- Private funding (2018)
- 1 clinical trial
- FDA-cleared or approved devices
- Research grants: $2.1 million
Life science companies
Explore 34,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Icagen, Inc.
- Raised $7.3 million (2018)
- 5 clinical trials
- Research grants: $6.6 million
Akebia Therapeutics, Inc.
Nasdaq: AKBA
- Raised $14 million (2011)
- 37 clinical trials, 3 active
- Founded 2007
Talphera, Inc.
Nasdaq: TLPH
- Raised $17 million (2025)
- 18 clinical trials, 1 active
Vida Diagnostics Inc
- Raised $11 million (2023)
- FDA-cleared or approved devices
- Research grants: $3 million
- Founded 2005
ACTIV Surgical, Inc.
- Raised $15 million (2022)
- 5 clinical trials, 1 active
- Research grants: $485,538
- Founded 2014
Alessa Therapeutics, Inc.
- Raised $25 million (2025)
- 3 clinical trials, 2 active
- Research grants: $1.6 million
- Founded 2018
GRAIL, Inc.
Nasdaq: GRAL
- Raised $325 million (2025)
- 8 clinical trials, 5 active
- Founded 2015
Kura Oncology, Inc.
Nasdaq: KURA
- Raised $150 million (2024)
- 17 clinical trials, 6 active
NextCure, Inc.
Nasdaq: NXTC
- Raised $22 million (2025)
- 8 clinical trials, 2 active
- Founded 2015
Paradromics, Inc.
- Raised $50 million (2023)
- 1 clinical trial, 1 active
- Research grants: $7.9 million
- Founded 2015
Shape Medical Systems, Inc.
- Raised $8.3 million (2012)
- 2 clinical trials
- FDA-cleared or approved devices
- Research grants: $4.1 million
Spruce Biosciences, Inc.
Nasdaq: SPRB
- Raised $50 million (2025)
- 8 clinical trials, 1 active
- Founded 2016
Strand Therapeutics Inc.
- Raised $108 million (2026)
- 2 clinical trials, 2 active
- Research grants: $2 million
- Founded 2017
Veralox Therapeutics Inc.
- Raised $24 million (2023)
- 3 clinical trials
- Research grants: $1.2 million
- Founded 2018
Inflammatix, Inc.
- Raised $102 million (2021)
- 6 clinical trials, 1 active
- Research grants: $4.5 million
- Founded 2016
Protego Biopharma, Inc.
- Raised $33 million (2025)
- 1 clinical trial
- Research grants: $7.4 million
Vyriad, Inc.
- Raised $24 million (2019)
- 6 clinical trials, 3 active
- Research grants: $9.1 million
Carlsmed, Inc.
Nasdaq: CARL
- Raised $30 million (2022)
- FDA-cleared or approved devices
- Founded 2018
Atea Pharmaceuticals, Inc.
Nasdaq: AVIR
- Raised $107 million (2020)
- 36 clinical trials, 4 active
- Founded 2012
Showing 440 of 34,266 companies
Load morePublished company profiles only; counts update daily. Data licences